Dr Dayne Beccano-Kelly

Dr Dayne Beccano-Kelly’s research focuses on synaptic changes that contribute to the earliest stages and progression of neurodegeneration. After completing a BSc and PhD (in Biochemistry and Electrophysiology in Alzheimer’s respectively) at the University of Leeds, he undertook postdoctoral work at the University of Dundee and the University of British Columbia, focusing on synaptic biology in Alzheimer's and Parkinson’s. He began a Parkinson’s UK Career Development Fellowship at the University of Oxford in 2015, incorporating stem cell technology into his work. In 2021, Dr Beccano-Kelly received the prestigious Future Leaders Fellowship from UK Research & Innovation, joining the UK DRI as a Group Leader.